Stoke Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.

CEO

Edward M. Kaye

CEOEdward M. Kaye

Employees

102

Employees102

Headquarters

Bedford, Massachusetts

HeadquartersBedford, Massachusetts

Founded

2014

Founded2014

Employees

102

Employees102

STOK Key Statistics

Market cap

302.43M

Market cap302.43M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

271.94K

Average volume271.94K

High today

$7.69

High today$7.69

Low today

$7.01

Low today$7.01

Open price

$7.13

Open price$7.13

Volume

160.47K

Volume160.47K

52 Week high

$26.60

52 Week high$26.60

52 Week low

$6.88

52 Week low$6.88

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

STOK Earnings

-$0.71

-$0.35

$0.00

$0.36

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 9, Pre-Market

ActualExpected Mar 9, Pre-Market

Stoke Therapeutics

Why Robinhood?

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. Show more

STOK Key Statistics

Analyst ratings

100%

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.